On June 14, Philips Healthcare Solutions announced a recall of between three and four million Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP) machines and mechanical ventilator devices used to treat sleep apnea.

The recall announcement states that the polyester-based polyurethane noise-reducing foam used in the devices can break down over time, creating small particles that could be inhaled or ingested by users. As it degrades, this foam produces toxic gases which may cause harmful side effects.

Philips CPAP and Ventilator Side Effects Include:

• Lung cancer
• Lung disease
• Throat cancer
• Mouth cancer
• Skin Cancer
• Inflammation of the brain
• Kidney or Liver Damage
• Liver Cancer
• Kidney Cancer
• Asthma
• COPD
• Respiratory issues
• Hospitalization due to Inflammation, Headache, or Burns
• Eye Damage

*Chemical and particulate exposure may also lead to throat and lung cancer.

Which Philips Devices Are Being Recalled?

• Trilogy 100
• Trilogy 200
• Garbin Plus, Aeris, LifeVent
• A-Series BiPAP Hybrid A30 (not marketed in the U.S.)
• A-Series BiPAP V30 Auto
• A-Series BiPAP A40
• A-Series BiPAP A30
• E30 (Emergency Use Authorization)
• DreamStation ASV
• DreamStation ST, AVAPS
• SystemOne ASV4
• C-Series ASV
• C-Series S/T and AVAPS
• OmniLab Advanced+
• SystemOne (Q-Series)
• DreamStation
• DreamStation Go
• Dorma 400
• Dorma 500
• REMstar SE Auto

Are You Affected by the Philips CPAP Machine Recall? Contact us today so our team can fight for you!